Very short or long pregnancy intervals linked to autism?
Women who become pregnant again within a year of birth or more than 5 years later may be at increased risk of having a child with autism spectrum disorder (ASD), according to a recent study.
Women who become pregnant again within a year of birth or more than 5 years later may be at increased risk of having a child with autism spectrum disorder (ASD), according to a recent study in the Journal of the American Academy of Child and Adolescent Psychiatry.
Led by Columbia University, the research was conducted through the Finnish Prenatal Study of Autism, based in a national birth cohort. The Finnish Hospital Discharge Register was used to identify children born in Finland between 1987 and 2005 and those diagnosed with an ASD by 2007. Overall, 2208 non-firstborn children with an ASD and 5163 matched controls were included. Conditional logistic regression, adjusted for any potential confounder, was used to determine any association between ASD and interpregnancy intervals (IPIs).
Menopause: What's the impact of hot flashes on productivity?
When compared with births that had an IPI of 24 to 59 months, those with an IPI of <12 months had an increased risk of ASD (odds ratio [OR] = 1.50, 95% confidence interval [CI] = 1.28, 1.74) on models adjusted for confounders. The ORs for longer IPIs, 60 to 119 months and ≥120 months, were 1.28 (95% CI = 1.08, 1.52) and 1.44 (95% CI = 1.12, 1.85), respectively.
Investigators concluded that there is evidence that longer and very short IPIs can increase the risk of ASD.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
